Skip to content
10-Q

Quarterly Report

BioPlus Acquisition Corp.

0001193125-22-277012

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$460.97K
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$10.23K
Stockholders Equity Q3 2022 · Sep 30, 2022 −$14.46M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$14.17M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$13.86M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$13.6M
Stockholders Equity Q3 2022 · Sep 30, 2021 $17.98K
Stockholders Equity Q3 2022 · Jun 30, 2021 $18.86K
Stockholders Equity Q3 2022 · Mar 31, 2021 $20K
Stockholders Equity Q3 2022 · Feb 10, 2021 $0
Current Liabilities Q3 2022 · Sep 30, 2022 $288.45K
Current Liabilities Q3 2022 · Dec 31, 2021 $179.14K
Total Liabilities Q3 2022 · Sep 30, 2022 $15.09M
Total Liabilities Q3 2022 · Dec 31, 2021 $14.98M
Current Assets Q3 2022 · Sep 30, 2022 $628.56K
Current Assets Q3 2022 · Dec 31, 2021 $1M
Total Assets Q3 2022 · Sep 30, 2022 $236.51M
Total Assets Q3 2022 · Dec 31, 2021 $235.98M
Net Income Q3 2022 · Sep 30, 2022 $659.13K
Net Income Q3 2022 · Sep 30, 2022 $422.23K
Net Income Q3 2022 · Jun 30, 2022 $24.92K
Net Income Q3 2022 · Mar 31, 2022 −$261.82K
Net Income Q3 2022 · Sep 30, 2021 −$877
Net Income Q3 2022 · Sep 30, 2021 −$7.02K
Net Income Q3 2022 · Jun 30, 2021 −$1.14K
Net Income Q3 2022 · Mar 31, 2021 −$5K
Operating Income Q3 2022 · Sep 30, 2022 −$290.37K
Operating Income Q3 2022 · Sep 30, 2022 −$852.98K
Operating Income Q3 2022 · Sep 30, 2021 −$877
Operating Income Q3 2022 · Sep 30, 2021 −$7.02K